BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28699174)

  • 1. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Gu F; Zhang H; Hyland PL; Berndt S; Gapstur SM; Wheeler W; Ellipse Consortium T; Amos CI; Bezieau S; Bickeböller H; Brenner H; Brennan P; Chang-Claude J; Conti DV; Doherty JA; Gruber SB; Harrison TA; Hayes RB; Hoffmeister M; Houlston RS; Hung RJ; Jenkins MA; Kraft P; Lawrenson K; McKay J; Markt S; Mucci L; Phelan CM; Qu C; Risch A; Rossing MA; Wichmann HE; Shi J; Schernhammer E; Yu K; Landi MT; Caporaso NE
    Int J Cancer; 2017 Nov; 141(9):1794-1802. PubMed ID: 28699174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
    Scarbrough PM; Weber RP; Iversen ES; Brhane Y; Amos CI; Kraft P; Hung RJ; Sellers TA; Witte JS; Pharoah P; Henderson BE; Gruber SB; Hunter DJ; Garber JE; Joshi AD; McDonnell K; Easton DF; Eeles R; Kote-Jarai Z; Muir K; Doherty JA; Schildkraut JM
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):193-200. PubMed ID: 26637267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian genes and risk of prostate cancer: Findings from the EPICAP study.
    Wendeu-Foyet MG; Koudou Y; Cénée S; Trétarre B; Rébillard X; Cancel-Tassin G; Cussenot O; Boland A; Bacq D; Deleuze JF; Lamy PJ; Mulot C; Laurent-Puig P; Truong T; Menegaux F
    Int J Cancer; 2019 Oct; 145(7):1745-1753. PubMed ID: 30665264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study.
    Wendeu-Foyet MG; Cénée S; Koudou Y; Trétarre B; Rébillard X; Cancel-Tassin G; Cussenot O; Boland A; Olaso R; Deleuze JF; Blanché H; Lamy PJ; Mulot C; Laurent-Puig P; Truong T; Menegaux F
    Int J Cancer; 2020 Dec; 147(11):3119-3129. PubMed ID: 32506468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian genes and risk of prostate cancer in the prostate cancer prevention trial.
    Chu LW; Till C; Yang B; Tangen CM; Goodman PJ; Yu K; Zhu Y; Han S; Hoque AM; Ambrosone C; Thompson I; Leach R; Hsing AW
    Mol Carcinog; 2018 Mar; 57(3):462-466. PubMed ID: 29318656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian clockwork machinery in neural retina: evidence for the presence of functional clock components in photoreceptor-enriched chick retinal cell cultures.
    Chaurasia SS; Pozdeyev N; Haque R; Visser A; Ivanova TN; Iuvone PM
    Mol Vis; 2006 Mar; 12():215-23. PubMed ID: 16604054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association study of circadian genes with seasonal pattern in bipolar disorders.
    Geoffroy PA; Lajnef M; Bellivier F; Jamain S; Gard S; Kahn JP; Henry C; Leboyer M; Etain B
    Sci Rep; 2015 May; 5():10232. PubMed ID: 25989161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
    Mocellin S; Tropea S; Benna C; Rossi CR
    BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLOCK and NPAS2 have overlapping roles in the circadian oscillation of arylalkylamine N-acetyltransferase mRNA in chicken cone photoreceptors.
    Haque R; Ali FG; Biscoglia R; Abey J; Weller J; Klein D; Iuvone PM
    J Neurochem; 2010 Jun; 113(5):1296-306. PubMed ID: 20345751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
    Hung RJ; Ulrich CM; Goode EL; Brhane Y; Muir K; Chan AT; Marchand LL; Schildkraut J; Witte JS; Eeles R; Boffetta P; Spitz MR; Poirier JG; Rider DN; Fridley BL; Chen Z; Haiman C; Schumacher F; Easton DF; Landi MT; Brennan P; Houlston R; Christiani DC; Field JK; Bickeböller H; Risch A; Kote-Jarai Z; Wiklund F; Grönberg H; Chanock S; Berndt SI; Kraft P; Lindström S; Al Olama AA; Song H; Phelan C; Wentzensen N; Peters U; Slattery ML; ; Sellers TA; ; Casey G; Gruber SB; ; Hunter DJ; ; Amos CI; Henderson B;
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26319099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.
    Zhu Y; Stevens RG; Hoffman AE; Fitzgerald LM; Kwon EM; Ostrander EA; Davis S; Zheng T; Stanford JL
    Cancer Res; 2009 Dec; 69(24):9315-22. PubMed ID: 19934327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian clock genes and risk of fatal prostate cancer.
    Markt SC; Valdimarsdottir UA; Shui IM; Sigurdardottir LG; Rider JR; Tamimi RM; Batista JL; Haneuse S; Flynn-Evans E; Lockley SW; Czeisler CA; Stampfer MJ; Launer L; Harris T; Smith AV; Gudnason V; Lindstrom S; Kraft P; Mucci LA
    Cancer Causes Control; 2015 Jan; 26(1):25-33. PubMed ID: 25388799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility.
    Soria V; Martínez-Amorós E; Escaramís G; Valero J; Crespo JM; Gutiérrez-Zotes A; Bayés M; Martorell L; Vilella E; Estivill X; Menchón JM; Gratacòs M; Urretavizcaya M
    J Pineal Res; 2010 Aug; 49(1):35-44. PubMed ID: 20459461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
    Fehringer G; Kraft P; Pharoah PD; Eeles RA; Chatterjee N; Schumacher FR; Schildkraut JM; Lindström S; Brennan P; Bickeböller H; Houlston RS; Landi MT; Caporaso N; Risch A; Amin Al Olama A; Berndt SI; Giovannucci EL; Grönberg H; Kote-Jarai Z; Ma J; Muir K; Stampfer MJ; Stevens VL; Wiklund F; Willett WC; Goode EL; Permuth JB; Risch HA; Reid BM; Bezieau S; Brenner H; Chan AT; Chang-Claude J; Hudson TJ; Kocarnik JK; Newcomb PA; Schoen RE; Slattery ML; White E; Adank MA; Ahsan H; Aittomäki K; Baglietto L; Blomquist C; Canzian F; Czene K; Dos-Santos-Silva I; Eliassen AH; Figueroa JD; Flesch-Janys D; Fletcher O; Garcia-Closas M; Gaudet MM; Johnson N; Hall P; Hazra A; Hein R; Hofman A; Hopper JL; Irwanto A; Johansson M; Kaaks R; Kibriya MG; Lichtner P; Liu J; Lund E; Makalic E; Meindl A; Müller-Myhsok B; Muranen TA; Nevanlinna H; Peeters PH; Peto J; Prentice RL; Rahman N; Sanchez MJ; Schmidt DF; Schmutzler RK; Southey MC; Tamimi R; Travis RC; Turnbull C; Uitterlinden AG; Wang Z; Whittemore AS; Yang XR; Zheng W; Buchanan DD; Casey G; Conti DV; Edlund CK; Gallinger S; Haile RW; Jenkins M; Le Marchand L; Li L; Lindor NM; Schmit SL; Thibodeau SN; Woods MO; Rafnar T; Gudmundsson J; Stacey SN; Stefansson K; Sulem P; Chen YA; Tyrer JP; Christiani DC; Wei Y; Shen H; Hu Z; Shu XO; Shiraishi K; Takahashi A; Bossé Y; Obeidat M; Nickle D; Timens W; Freedman ML; Li Q; Seminara D; Chanock SJ; Gong J; Peters U; Gruber SB; Amos CI; Sellers TA; Easton DF; Hunter DJ; Haiman CA; Henderson BE; Hung RJ; ; ; ; ;
    Cancer Res; 2016 Sep; 76(17):5103-14. PubMed ID: 27197191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.
    Zhu Y; Leaderer D; Guss C; Brown HN; Zhang Y; Boyle P; Stevens RG; Hoffman A; Qin Q; Han X; Zheng T
    Int J Cancer; 2007 Jan; 120(2):432-5. PubMed ID: 17096334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants in ARNTL and NPAS2 and at chromosome 12p13 are associated with objectively measured sleep traits in the elderly.
    Evans DS; Parimi N; Nievergelt CM; Blackwell T; Redline S; Ancoli-Israel S; Orwoll ES; Cummings SR; Stone KL; Tranah GJ; ;
    Sleep; 2013 Mar; 36(3):431-46. PubMed ID: 23449886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.
    Shiels MS; Engels EA; Shi J; Landi MT; Albanes D; Chatterjee N; Chanock SJ; Caporaso NE; Chaturvedi AK
    Cancer; 2012 Nov; 118(22):5630-6. PubMed ID: 23044494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian genes and breast cancer susceptibility in rotating shift workers.
    Monsees GM; Kraft P; Hankinson SE; Hunter DJ; Schernhammer ES
    Int J Cancer; 2012 Dec; 131(11):2547-52. PubMed ID: 22473669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.